Abattis Partners with the CSE and Stockpools
Vancouver, British Columbia--(Newsfile Corp. - July 13, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") has partnered with the Canadian Securities Exchange ("CSE"), Stockpools and Lift Cannabis Expo to educate market players on the cannabis industry through an innovative fantasy online stock trading competition focused entirely on the cannabis sector titled, "The 2017 Cannabis Investment Challenge". Abattis is the title sponsor for this competition...
2017-07-13 9:18 AM EDT
Abattis Adds Key Executive and Management Positions
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the following key additions to our Executive and Management team, Anthony Jackson as Chief Financial Officer ("CFO"), Christina Boddy as Corporate Secretary, John Kaye as head of Corporate Development and Clayton Chessa as head of Operations. All positions will report directly to Robert Abenante, President and CEO of...
2017-06-15 10:02 AM EDT
Abattis Provides Company Update
Vancouver, British Columbia--(Newsfile Corp. - June 13, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to provide an update of recent developments and achievements.Testing Revenues at Northern Vine LabsTMSince the launch of its first lab in May of 2017, the Company's subsidiary, Northern Vine Canada Inc. ("Northern Vine"), has been successfully accepting cannabis flower, oil and edible samples at its lab in Langley, BC. The team of...
2017-06-13 10:40 AM EDT
Abattis Announces New Board Members
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce the appointment of Robert Abenante and Peter Gordon to its Board of Directors.Mr. Abenante is the President and CEO of Abattis and its subsidiaries. He is a seasoned executive who has served as a board member and executive officer of several public and private companies. Mr. Abenante's experience spans across several...
2017-06-07 9:30 AM EDT
Abattis: Northern Vine Labs Expands Its Sales Team
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce the addition of Siobhan McCarthy as Sales & Marketing Manager for the Company's subsidiary Northern Vine Canada Inc. ("Northern Vine").Ms. McCarthy brings more than 20 years of direct sales and marketing experience to the Company and will lead the drive in generating testing and service revenues in Northern Vine. Ms. McCarthy...
2017-05-10 2:17 PM EDT
Abattis Announces the Official Launch of Northern Vine Laboratory
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that its subsidiary, Northern Vine Canada Inc. ("Northern Vine"), has officially launched its flagship laboratory, having completed its first successful test analysis."I am very pleased to announce this significant milestone in our Company's development," said Robert Abenante, President and CEO of Abattis and Northern Vine. "I...
2017-05-03 9:20 AM EDT
Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology
Vancouver, British Columbia--(Newsfile Corp. - April 26, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce it has signed an exclusive distribution agreement effective April 20, 2017 (the "Agreement") with Suzhou Raybot Material Tech Corp. ("Raybot"). The Agreement allows Abattis to use Raybot's proprietary extraction technology and to exclusively sell the extraction equipment and services.Raybot has developed a proprietary...
2017-04-26 10:02 AM EDT
Abattis Bioceuticals Announces New CEO
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis"), is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company.Mr. Abenante is a seasoned executive with extensive public company experience. Mr. Abenante is a Chartered Professional Accountant (CPA, CA) who also holds a Masters. After his tenures with PricewaterhouseCoopers and Deloitte, Mr....
2017-04-10 9:58 AM EDT
Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC
Vancouver, British Columbia--(Newsfile Corp. - April 6, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector. The North American Marijuana Index tracks the leading public cannabis companies operating in the United States and Canada and gives investors up to date, centralized news on the securities deemed to be well positioned within the...
2017-04-06 8:47 AM EDT
Abattis: Legislation To Legalize Marijuana In Canada Is Being Announced Next Month
Vancouver, British Columbia--(Newsfile Corp. - March 27, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), and its subsidiary, Northern Vine Labs is anticipating the Liberal government's upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018.As reported by the CBC, Trudeau's government will follow the recommendations of a federally appointed task force, led...
2017-03-27 2:01 PM EDT
Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine's Science Advisory efforts.Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned expert in the formulation and commercialization of botanical-based products with a focus on using traditional, non...
2017-03-20 11:40 AM EDT
Abattis Team Positions for Next Stage of Growth
Vancouver, British Columbia--(Newsfile Corp. - March 13, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern Vine Labs continues, more key management hires and appointments will accompany this next stage of growth. Jaclyn will join...
2017-03-13 9:06 AM EDT
Abattis Completes Audit and Prepares to Launch Northern Vine Labs
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) ("ATT" or the "Company") is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and subsequent review.Management has been focusing their efforts on their Northern Vine Lab buildout after receiving their...
2017-02-24 5:55 PM EST
Abattis Bioceuticals Corp. Announces Postponement of Its Annual General Meeting
Vancouver, British Columbia--(Newsfile Corp. - February 14, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company") is announcing today that it will be seeking to adjourn its upcoming annual general meeting of shareholders, originally scheduled to be held on Friday, February 17, 2017, at 10:00 a.m. (Vancouver time) (the "Meeting"), to a to-be-announced date. The Company will seek to hold the adjourned meeting as soon as practicable. As of this time, no changes are...
2017-02-14 3:00 PM EST
Abattis Audit Update
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2017) - Abattis Bioceuticals Corp., (OTCQB: ATTBF) (CSE: ATT) ("ATT" or the "Company") announces that it is completing work on its audit and has been working with its auditor to complete the process in order to have it ready to file as soon as possible. It is anticipated that this delay will result in a temporary issuer cease trade order which Abattis shall seek to remove as soon as the audited financial...
2017-02-03 4:00 PM EST
Abattis Announces An Independent Valuation On Green Nature Health Care Products
Vancouver, British Columbia--(Newsfile Corp. - January 16, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), provides an update to its shareholders.Abattis Bioceuticals Corp. has begun an independent valuation on Green Nature Health Care Products Inc., after the company posted strong performance within their existing and upcoming product catalogue in both Q3 and Q4 of 2016. Green Nature, with which Abattis entered into an international licensing and...
2017-01-16 1:41 PM EST
Abattis Issues Common Shares
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2016) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), announces that today the Company issued 534,389 common shares as compensation for services to consultants, directors and employees of the Company for the month ended November 30, 2016 and in respect of prior months outstanding, no legend was required on any of the issued shares. Abattis is also pleased to announced that it has been included the...
2016-12-16 6:28 PM EST
Abattis Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2016) - Abattis Bioceuticals Corp. (OTCQX: ATTBF) (CSE: ATT) (the "Company" or "Abattis") provides an update to its shareholder.CEO Rene David provides an update to shareholders after reviewing the latest report from the Canadian Cannabis Task Force on Legalization and Regulation."After having a chance to review the report, we are even more excited about how the Canadian Cannabis industry will look post-legalization. A few key items...
2016-12-16 8:50 AM EST
Abattis Announced Private Placement Agreement of Up To $5,000,000
Vancouver, British Columbia--(Newsfile Corp. - December 8, 2016) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce that the Company entered into a non-binding agreement for a draw-down equity facility of up to $5,000,000 CAD. The agreement provides for equity private placement offerings (the "Offerings"), to be conducted between Abattis and Alumina Partners (Ontario) Ltd. ("Alumina Partners"), a subsidiary of Alumina Partners LLC, a...
2016-12-08 5:09 PM EST
Abattis Issues Shares and Units
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2016) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), announces that it intends to issue 1,354,149 Units to a consultant of the Company in satisfaction of sums owed; each unit costs of one common share and one common share purchase warrant. The warrants have an 18-month term and are exercisable at $0.16/common share. The shares were purchased under an exemption from prospectus requirements...
2016-11-21 8:53 PM EST